912962-41-5

Upstream product

• 487-89-8 Indole-3-carboxaldehyde 
• 104-83-6 1-Chloro-4-(chloromethyl)benzene 
• 75629-57-1 oncrasin-1 
• 926622-90-4 [4-(tert-butyl-dimethyl-silanyloxymethyl)-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-[1-(4-chloro-benzyl)-1H-indol-3-yl]-methanol 
• 501660-44-2 [4-(tert-butyl-dimethyl-silanyloxymethyl)-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-[1-(4-chloro-benzyl)-1H-indol-3-yl]-methanone 
• 501660-45-3 [1-(4-Chlorobenzyl)-1H-indol-3-yl-]-[4-hydroxymethyl-1-(2-trimethylsilanylethoxy-methyl)-1H-imidazol-2-yl]methanone 
• 501660-43-1 4-(((tert-butyldimethylsilyl)oxy)methyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole 
• 501660-46-4 2-[1-(4-Chlorobenzyl)-1H-indole-3-carbonyl]-1-(2-trimethylsilanylethoxymethyl)-1H-imidazole-4-carbaldehyde 
• 925-90-6 ethylmagnesium bromide 

Downstream Products

• 926622-92-6 [1-(4-chloro-benzyl)-1H-indol-3-yl]-[4-(1-hydroxy-propyl)-1H-imidazol-2-yl]-methanone 

Relevant academic research and scientific papers

Conjugated indole-imidazole derivatives displaying cytotoxicity against multidrug resistant cancer cell lines

We report herein the SAR studies of a series of indole-imidazole compounds. that demonstrate substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes. The in vitro cytotoxic effects have